| PACKAGING TYPE: | 1x21 C-box |
| COMPOSITION: | Palbociclib 125mg |
| FORMULATION: | Capsules |
| Description: | PALCICLIB-125 Capsule contains Palbociclib 125 mg, a targeted anticancer medication belonging to the class of CDK4/6 inhibitors. It is primarily used in the treatment of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer. Palbociclib works by inhibiting cyclin-dependent kinases 4 and 6, which are responsible for cell division, thereby slowing down or stopping the growth of cancer cells. It is often used in combination with hormonal therapies to improve treatment outcomes. |
| Side Effects: | Neutropenia (low white blood cell count) Fatigue Nausea Hair thinning Diarrhea Infections Rare: Severe bone marrow suppression |
| How to Use: | Take the capsule as prescribed by an oncologist Usually taken once daily for 21 days followed by 7 days off (treatment cycle) Swallow whole with water; do not crush or chew Can be taken with or without food Follow exact dosing schedule strictly |
| Precaution: | Use only under strict medical supervision Regular blood count monitoring required Avoid during pregnancy or breastfeeding Use effective contraception during treatment Inform doctor about all medications Avoid exposure to infections due to lowered immunity |
| Product Benefits: | Targeted therapy for breast cancer Inhibits cancer cell growth and division Improves progression-free survival Effective in HR+ and HER2-negative breast cancer Oral administration for patient convenience Used in combination with endocrine therapy for |
Frequently Asked Questions
It is used to treat HR-positive, HER2-negative advanced or metastatic breast cancer.
It blocks CDK4/6 proteins, preventing cancer cell division and growth.
Yes, regular blood tests are necessary to monitor white blood cell counts.










